Gena L. Ashe - May 17, 2022 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Chief Legal Officer & Corp Sec
Signature
/s/ Gena Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
May 17, 2022
Transactions value $
$0
Form type
4
Date filed
5/19/2022, 04:15 PM
Previous filing
Mar 2, 2022
Next filing
Jun 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATEX Common Stock Award $0 +9.11K +27.04% $0.00 42.8K May 17, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +18.4K $0.00 18.4K May 17, 2022 Common Stock 18.4K $49.39 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 17, 2023, with the remaining RSUs vesting in 3 equal annual installments thereafter.
F2 25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney